Depreciation of CERO THERAPEUTICS HOLDINGS, INC. from 31 Mar 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: CERO THERAPEUTICS HOLDINGS, INC. quarterly Depreciation in USD history and change rate from 31 Mar 2023 to 30 Sep 2025.
CERO THERAPEUTICS HOLDINGS, INC. Depreciation for the quarter ending 30 Sep 2025 was $69,354, a 39% decline year-over-year.
Source SEC data: View on sec.gov

Depreciation, Trailing 12 Months (USD)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Change (%)

CERO THERAPEUTICS HOLDINGS, INC. Quarterly Depreciation (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025		$69,354	-$44,501	-39%	01 Jul 2025	30 Sep 2025	10-Q	19 Nov 2025	2025	Q3
Q2 2025		$76,294	-$38,010	-33%	01 Apr 2025	30 Jun 2025	10-Q	22 Aug 2025	2025	Q2
Q1 2025		$76,294	+$7	+0.01%	01 Jan 2025	31 Mar 2025	10-Q	15 May 2025	2025	Q1
Q3 2024	$341,802	$113,855	-$1,533	-1.3%	01 Jul 2024	30 Sep 2024	10-Q	19 Nov 2025	2025	Q3
Q2 2024	$343,335	$114,304	-$1,084	-0.94%	01 Apr 2024	30 Jun 2024	10-Q	22 Aug 2025	2025	Q2
Q1 2024	$344,419	$76,287	-$39,101	-34%	14 Feb 2024	31 Mar 2024	10-Q	15 May 2025	2025	Q1
Q4 2023		$37,356			01 Jan 2024	13 Feb 2024	10-Q	22 Aug 2025	2025	Q2
Q3 2023		$115,388			01 Jul 2023	30 Sep 2023	10-Q/A	20 Nov 2024	2024	Q3
Q2 2023		$115,388			01 Apr 2023	30 Jun 2023	10-Q	14 Aug 2024	2024	Q2
Q1 2023		$115,388			01 Jan 2023	31 Mar 2023	10-Q	17 May 2024	2024	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.